Serum anti-CSP antibodies derived from individuals living in malaria-endemic regions or those immunized with different formulations have been shown to possess neutralizing capabilities against Pf sporozoites (reviewed by 5, 60), reduce the hypnozoite burden, and delay the onset of blood-stage Pv infection (61). This evidence concerns the gene DNAJC5 and malaria.